CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback